For the Inventor, By the Inventor

Enter assignee name

Concord, CA, United States of America

Microgenics Corporation

USPTO Granted Patents = 26

% Expired Patents = 3.8

Trademarks = 10

Forward Citations = 332

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Pyare L Khanna (12 out of 53 patents)

Daniel R Henderson (4 out of 4 patents)

Gerald F Sigler (3 out of 28 patents)

4. Riaz Rouhani (3 out of 6 patents)

5. William A Coty (3 out of 4 patents)

6. Glenda L Choate (3 out of 4 patents)

7. Rueyming Loor (2 out of 2 patents)

8. David Davoudzadeh (2 out of 3 patents)

9. Jeffrey E Shindelman (2 out of 2 patents)

10. Robert T Dworschack (2 out of 2 patents)

11. Stephen B Friedman (2 out of 2 patents)

12. David S Kates (2 out of 2 patents)

13. Aniruddha Patwardhan (1 out of 14 patents)

14. Imad Nashashibi (1 out of 16 patents)

15. Cynthia A Vistica (1 out of 4 patents)

Core Competencies:

Immunoassay

Mitragynine

Levetiracetam

Mycophenolic Acid

Ecstasy-Class Compounds

Protein Binding

Enzyme Complementation

Methadone Metabolite

LSD Metabolites

Drug Screening

Thyroxine Bending Sites

Assay Stabilization

26 patents: Sort by Forward Citations

1. 11578140 - Immunoassay for mitragynine (2023-02-14),

2. 8846411 - Derivatives, reagents, and immunoassay for detecting levetiracetam (2014-09-30),

3. 7138504 - Reagents and methods for mycophenolic acid immunoassay (2006-11-21),

4. 6946547 - Ecstasy-class analogs and use of same in detection of ecstasy-class compounds (2005-09-20),

5. 6306616 - Adsorption type confirmatory assays (2001-10-23),

6. 6262265 - Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay (2001-07-17),

7. 6207396 - Immunoassay reagents and methods for determination of LSD and LSD metabolites (2001-03-27),

8. 6140137 - Conjugates and specific immunoassays for the methadone metabolite (2000-10-31),

9. 5643734 - Methods for protein binding enzyme complementation assays (1997-07-01),

10. 5604091 - Methods for protein binding enzyme complementation (1997-02-18),

11. 5573955 - Reducing tyramine interference in immunoassays for amphetamine and (1996-11-12),

12. 5444161 - Substrates for .beta.-galactosidase (1995-08-22),

13. 5434052 - Complementation assay for drug screening (1995-07-18),

14. 5362625 - Methods and compositions for enzyme complementation assays using the (1994-11-08),

15. 5244786 - Method of measuring available free thyroxine bending sites (1993-09-14),

Company Overview

Microgenics Corporation, based in Concord, California, specializes in the development and manufacturing of diagnostic products and technologies. The company focuses on providing innovative solutions for clinical laboratories, particularly in the areas of immunoassay and molecular diagnostics. With a commitment to enhancing patient care, Microgenics leverages advanced research to deliver high-quality, reliable testing solutions that support healthcare professionals in making informed decisions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

26 Patents

#8 in Concord, CA

#3,043 in California

#12,865 in US

#24,826 in the World

Concord, CA, United States of America

Microgenics Corporation

Forward Citations = 332

40 inventors:

Pyare L Khanna (12 out of 53 patents)

Daniel R Henderson (4 out of 4 patents)

Gerald F Sigler (3 out of 28 patents)

4. Riaz Rouhani (3 out of 6 patents)

5. William A Coty (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Microgenics Corporation. Retrieved from https://idiyas.com/company/microgenics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…